Liu Y, Chen X, Evan T, Esapa B, Chenoweth A, Cheung A
MAbs. 2025; 17(1):2470309.
PMID: 40045156
PMC: 11901361.
DOI: 10.1080/19420862.2025.2470309.
Auchynnikava T, Aarela A, Moisio O, Liljenback H, Andriana P, Iqbal I
ACS Omega. 2025; 10(6):6003-6014.
PMID: 39989783
PMC: 11840764.
DOI: 10.1021/acsomega.4c10047.
Cerreto G, Pozzi G, Cortellazzi S, Pasini L, Di Martino O, Mirandola P
Ann Hematol. 2025; 104(1):35-46.
PMID: 39847116
PMC: 11868374.
DOI: 10.1007/s00277-024-06176-y.
Cong Y, Abulimiti M, Matsumoto Y, Jin J
Front Oncol. 2024; 14:1507157.
PMID: 39726703
PMC: 11669655.
DOI: 10.3389/fonc.2024.1507157.
Bethke M, Abramowski P, Droste M, Felsberger A, Kochsiek L, Kotter B
Cells. 2024; 13(22).
PMID: 39594628
PMC: 11592683.
DOI: 10.3390/cells13221880.
The Efficacy and Safety of Folate Receptor α-Targeted Antibody-Drug Conjugate Therapy in Patients With High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers: A Systematic Review and Meta-Analysis.
Kim E, Kim J, Park E, Song I, Park H, Park S
Cancer Med. 2024; 13(21):e70392.
PMID: 39526448
PMC: 11551784.
DOI: 10.1002/cam4.70392.
Prospects for Fluorescence Molecular Liquid Biopsy of Circulating Tumor Cells in Humans.
Niedre M
Front Photon. 2024; 3.
PMID: 39508030
PMC: 11540420.
DOI: 10.3389/fphot.2022.910035.
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.
Kesharwani P, Halwai K, Jha S, Mughram M, Salman Almujri S, Almalki W
Mol Cancer. 2024; 23(1):244.
PMID: 39482651
PMC: 11526716.
DOI: 10.1186/s12943-024-02163-z.
Effect of Cyclodextrins Formulated in Liposomes and Gold and Selenium Nanoparticles on siRNA Stability in Cell Culture Medium.
Castillo Cruz B, Chinapen Barletta S, Ortiz Munoz B, Benitez-Reyes A, Amalbert Perez O, Cardona Amador A
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458985
PMC: 11510567.
DOI: 10.3390/ph17101344.
Near fatal case of mirvetuximab soravtansine-gynx induced interstitial lung disease and a review of the primary literature.
Clark J, Blake A, Vasher S, Boucher R, Jones A, Choi H
Gynecol Oncol Rep. 2024; 55:101486.
PMID: 39281842
PMC: 11399687.
DOI: 10.1016/j.gore.2024.101486.
Synthesis and Characterization of Folic Acid-Conjugated Terbium Complexes as Luminescent Probes for Targeting Folate Receptor-Expressing Cells.
McMullon G, Ezdoglian A, Booth A, Jimenez-Royo P, Murphy P, Jansen G
J Med Chem. 2024; 67(16):14062-14076.
PMID: 39138970
PMC: 11345839.
DOI: 10.1021/acs.jmedchem.4c00919.
siRNA-loaded folic acid-modified TPGS alleviate MASH targeting ER stress sensor XBP1 and reprogramming macrophages.
Zhu M, Cheng Y, Zuo L, Bin B, Shen H, Meng T
Int J Biol Sci. 2024; 20(10):3823-3841.
PMID: 39113706
PMC: 11302883.
DOI: 10.7150/ijbs.96113.
Generic semi-automated radiofluorination strategy for single domain antibodies: [F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer.
Dierick H, Navarro L, Ceuppens H, Ertveldt T, Pombo Antunes A, Keyaerts M
EJNMMI Radiopharm Chem. 2024; 9(1):54.
PMID: 39048805
PMC: 11269545.
DOI: 10.1186/s41181-024-00286-8.
New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment-a narrative review.
Satora M, Kulak K, Zaremba B, Grunwald A, Swiechowska-Starek P, Tarkowski R
Front Pharmacol. 2024; 15:1416555.
PMID: 38948462
PMC: 11212463.
DOI: 10.3389/fphar.2024.1416555.
Research advances in Zein-based nano-delivery systems.
Liu X, Zhang M, Zhou X, Wan M, Cui A, Xiao B
Front Nutr. 2024; 11:1379982.
PMID: 38798768
PMC: 11119329.
DOI: 10.3389/fnut.2024.1379982.
Challenges in Pharmacokinetic Modelling of [F]fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer Patients.
Ruytenberg T, Ciggaar I, Peters I, Noortman W, Dibbets-Schneider P, de Muynck L
Mol Imaging Biol. 2024; 26(4):577-584.
PMID: 38775919
PMC: 11282117.
DOI: 10.1007/s11307-024-01922-0.
In Vivo Labeling and Detection of Circulating Tumor Cells in Mice Using OTL38.
Pace J, Lee J, Srinivasarao M, Kallepu S, Low P, Niedre M
Mol Imaging Biol. 2024; 26(4):603-615.
PMID: 38594545
PMC: 11281960.
DOI: 10.1007/s11307-024-01914-0.
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers.
Liu K, Li M, Li Y, Li Y, Chen Z, Tang Y
Mol Cancer. 2024; 23(1):62.
PMID: 38519953
PMC: 10960395.
DOI: 10.1186/s12943-024-01963-7.
Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis.
Ahmadi M, Ritter C, von Woedtke T, Bekeschus S, Wende K
Chem Sci. 2024; 15(6):1966-2006.
PMID: 38332833
PMC: 10848714.
DOI: 10.1039/d3sc05539f.
High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive.
Wilczynski J, Paradowska E, Wilczynski M
Biomedicines. 2024; 12(1).
PMID: 38275400
PMC: 10813374.
DOI: 10.3390/biomedicines12010229.